Labiotech.eu

20191008 Rheticus Evonik DEBO0495 freigegeben e1571095521515

News and Trends 15 Oct 2019

Artificial Photosynthesis-Driven Chemical Plant Launched in Germany

The German industrial giants Siemens and Evonik have launched a joint project to build and run a test plant to make valuable chemicals from water and waste carbon dioxide using bacteria — a process known as artificial photosynthesis. The test plant, which is currently under construction, will be based at Evonik’s site in Marl, Germany, […]

October 15, 2019 - 3 minutesmins - By Helen Albert

delft university Planet bio business incubator

News and Trends 14 Oct 2019

Dutch Incubator Launched to Scale up Industrial Biotechs

A collaboration involving the Dutch company DSM and other organizations in the Netherlands has launched Planet B.io, an incubator aimed at scaling up technology developed by industrial biotech startups such as the lab-grown meat developer Meatable. Planet B.io is based at the Biotech Campus Delft, the Netherlands, and contains a total of 3,000 m² of office […]

October 14, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Oct 2019

Mogrify Raises €15M Series A to Chase the ‘Holy Grail’ of Cell Therapy

Cambridge-based Mogrify has raised €14.5M to develop a technology that could allow scientists to transform any human cell into another cell type without the arduous process of turning them into a stem cell first. The Series A round was led by Ahren Innovation Capital, an investment firm founded by science entrepreneurs from the UK […]

October 14, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 11 Oct 2019

RNA Therapy Improves Vision in Untreatable Genetic Blindness

A phase I/II trial run by the Dutch company ProQR has found that its RNA therapy could significantly improve the vision of people with Leber’s congenital amaurosis, a rare genetic disease for which there is no treatment. The RNA drug, called sepofarsen, is designed to treat people with a specific mutation in a gene […]

October 11, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

stem cell therapy deafness rinri therapeutics

Startup Scout 11 Oct 2019

This Biotech Is Developing a Stem Cell Therapy for Deafness

Sheffield is one of the UK’s historic industrial bases. It also hosts the biotech Rinri Therapeutics, which is developing a stem cell therapy to treat deaf patients who are not eligible for cochlear implants. Mission: To develop a stem cell therapy for a rare form of deafness where the neuronal wiring underlying the auditory system […]

October 11, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 10 Oct 2019

Update: BioNTech Files for €141M Nasdaq IPO

BioNTech’s Nasdaq IPO has raised €141M ($155M), a lower sum than it initially anticipated. The timing of the IPO means it has likely been impacted by adverse market conditions, which are due to factors such as global manufacturing slowdowns and escalations in US and Chinese trade disputes. This same market volatility led several companies such […]

October 10, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 9 Oct 2019

Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing

The Danish big pharma Novo Nordisk has joined forces with the US gene therapy company bluebird bio to develop next-generation gene editing treatments for hemophilia. The collaboration will last for three years and has the goal of developing a gene therapy that can permanently treat hemophilia A, a genetic disease causing uncontrolled bleeding. Novo Nordisk […]

October 9, 2019 - 1 minutemin - By Jonathan Smith

acne s biomedic skinbiotherapeutics skin microbiome

News and Trends 8 Oct 2019

UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome

Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based on delivering live bacteria to the gut. The partners will develop vaccines against three undisclosed conditions. As well as an undisclosed upfront fee for each condition, 4D Pharma will be eligible to receive up to €316.5M ($347.5M) in developmental milestones. […]

October 8, 2019 - 2 minutesmins - By Jonathan Smith

Interview 8 Oct 2019

Biotech Hubs: A Tale of Two Cities

Life science investors differ widely across biotech hubs in Europe. At Labiotech’s recent Refresh event, two investors from Cambridge and Paris compared the progress of these hubs and discussed the challenges that need to be overcome in biotech investment. Funding is the lifeblood of early biotech startups, and investors are a crucial supplier. For this […]

October 8, 2019 - 6 minutesmins - By Jonathan Smith

aleph farms lab grown meat space mission

More News! 8 Oct 2019

Israeli Biotech 3D Prints the First Beef Steak in Space

Hungry astronauts rejoice! Aleph Farms, a company that grows beef steak from animal cells, has grown the first steaks aboard the International Space Station. The Israeli biotech’s experiment is the first proof that meat can be grown in outer space. Aleph Farms created the meat using a 3D bioprinter developed by the Russian company 3D […]

October 8, 2019 - 3 minutesmins - By Jonathan Smith

Expert Advice 8 Oct 2019

Why Good Teamwork is Key to Biotech Success

Teamwork is important throughout the development of a company, but never more so than in the early stages of a startup. Charlotte Edenius, co-founder and VP Business and Clinical development at Gesynta Pharma in Sweden, knows this well. With more than 20 years experience working in the industry, she knows how important it is for biotech leaders […]

October 8, 2019 - 10 minutesmins - By Helen Albert

More News! 7 Oct 2019

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

MiroBio has spun out of the University of Oxford with a Series A round of €30M (£27M) to develop treatments for autoimmune diseases that don’t disrupt the immune system as a whole. The big Series A round accompanying MiroBio’s launch was co-led by the university’s investor partner Oxford Sciences Innovation and the US investor Samsara […]

October 7, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Artificial Photosynthesis-Driven Chemical Plant Launched in Germany

Dutch Incubator Launched to Scale up Industrial Biotechs

Mogrify Raises €15M Series A to Chase the ‘Holy Grail’ of Cell Therapy

RNA Therapy Improves Vision in Untreatable Genetic Blindness

This Biotech Is Developing a Stem Cell Therapy for Deafness

Update: BioNTech Files for €141M Nasdaq IPO

Novo Nordisk and Bluebird Bio to Treat Hemophilia with Gene Editing

UK Company and Merck Team Up to Develop Vaccines Based on the Microbiome

Biotech Hubs: A Tale of Two Cities

Israeli Biotech 3D Prints the First Beef Steak in Space

Why Good Teamwork is Key to Biotech Success

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!